We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUN icon
651
Sunoco
SUN
$13.3B
$422K 0.06%
10,329
+2,292
+29% +$97.5K
ZVRA icon
652
Zevra Therapeutics
ZVRA
$686M
$422K 0.06%
+83,952
New +$534K
CRTO icon
653
Criteo S.A. Ordinary Shares
CRTO
$923M
$421K 0.06%
15,458
+8,937
+137% +$284K
VAC icon
654
Marriott Vacations Worldwide
VAC
$4.25B
$421K 0.06%
+2,671
New +$430K
CTSO icon
655
Cytosorbents Corp
CTSO
$22.6M
$420K 0.06%
131,655
+118,652
+912% +$425K
SNPS icon
656
Synopsys
SNPS
$79.7B
$420K 0.06%
1,260
-2,296
-65% -$717K
ALGN icon
657
Align Technology
ALGN
$12.3B
$419K 0.06%
+961
New +$468K
VKTX icon
658
Viking Therapeutics
VKTX
$4B
$419K 0.06%
139,664
+62,964
+82% +$226K
GPUS
659
Hyperscale Data Inc
GPUS
$55.4M
$419K 0.06%
3
DGII icon
660
Digi International
DGII
$3.1B
$418K 0.06%
+19,428
New +$415K
ALNY icon
661
Alnylam Pharmaceuticals
ALNY
$29.3B
$417K 0.06%
+2,554
New +$389K
OPTU
662
Optimum Communications Inc
OPTU
$301M
$417K 0.06%
33,403
+16,352
+96% +$219K
TDOC icon
663
Teladoc Health
TDOC
$1.3B
$417K 0.06%
+5,779
New +$416K
IPG
664
DELISTED
Interpublic Group of Companies
IPG
$416K 0.06%
+11,737
New +$423K
MOG.A icon
665
Moog Inc Class A
MOG.A
$12.8B
$416K 0.06%
4,742
-277
-6% -$22.4K
RAPT
666
DELISTED
RAPT Therapeutics
RAPT
$416K 0.06%
2,364
+1,266
+115% +$239K
HIW icon
667
Highwoods Properties
HIW
$3.47B
$415K 0.06%
9,083
-3,121
-26% -$138K
LTC
668
LTC Properties
LTC
$2.15B
$415K 0.06%
10,782
-17,596
-62% -$622K
KTOS icon
669
Kratos Defense & Security Solutions
KTOS
$11.4B
$414K 0.06%
20,233
-11,539
-36% -$211K
ZOM
670
DELISTED
Zomedica Corp.
ZOM
$414K 0.06%
1,228,059
+31,377
+3% +$10.3K
FPI
671
Farmland Partners
FPI
$432M
$413K 0.06%
+30,025
New +$364K
SRRK icon
672
Scholar Rock
SRRK
$6.44B
$413K 0.06%
+32,010
New +$547K
VERX icon
673
Vertex
VERX
$1.94B
$413K 0.06%
+26,921
New +$377K
FUV
674
DELISTED
Arcimoto, Inc. Common Stock
FUV
$413K 0.06%
3,125
-6,441
-67% -$837K
AA icon
675
Alcoa
AA
$13.2B
$412K 0.06%
+4,580
New +$333K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.